Total Credits: 1 including 1 AOA Category 1-A Credit(s), 1 AMA PRA Category 1 Credit(s)™
This session will teach primary providers concepts, treatments, and new drugs to consider when managing and treating patients with high cholesterol. It will include new and up-to-date treatments to help lower, manage, and control cholesterol in patients.
Review mechanism of action of agents.
Discuss the background of inflammation and its role in diseases.
Highlight guidelines and appropriate drugs to use and when.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation.
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this live activity for a maximum of 1 AMA PRA Category 1 Creditä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The MAOPS Education Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, then they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
|Evolving Lipid Management in the New Decade (23.1 MB)||89 Pages||Available after Purchase|
Dr. Martin Schwarze is a Clinical Professor of Medicine in the Division of Cardiology of St. Louis University Hospitals and the past Chief of Cardiology at Des Peres Hospital in St. Louis, Mo. He is currently a physician with the Barnes-Jewish Christian Medical Group.
Dr. Schwarze graduated from the AT Still University Kirksville College of Osteopathic Medicine (KCOM) in Kirksville, Missouri, in 1973. He completed his internship and residency in Internal Medicine at Normandy Osteopathic Hospital in St. Louis, Missouri. He then attended the fellowship program in Cardiology at St. Louis University Hospital, where he continued to teach echocardiology part-time for 15 years. Upon completing his fellowship, Dr.Schwarze established a private practice, which existed for 32 years. His group is now part of the BJC Medical Group in the Metropolitan St. Louis area. Dr. Schwarze is board certified in Internal Medicine and Cardiovascular Disease by the American Osteopathic Board of Internal Medicine.
Dr. Schwarze has researched echocardiology, congestive heart failure, and lipid therapy, which has resulted in several publications in these areas. He has spoken at numerous national programs and has been the program chairman of many educational symposia in cardiology. Dr. Schwarze has received four "Educator of the Year" awards and is a Master Fellow in the American College of Osteopathic Internists and a Fellow in the American College of Cardiology. He is also the past President of the St. Louis Chapter of the American Heart Association. He has received the Hugh McCollough Award and a Lifetime Achievement Award from the St. Louis Chapter of the AHA and a lifetime teaching award from Des Peres Hospital.
Dr. Schwarze discloses that he received speaker fees from BMS/Pfizer, Amgen, and Esperion.
Please wait ...